Bruker Announces Date and Time of Fourth Quarter 2021 Earnings Release and Webcast
February 02 2022 - 7:00AM
Business Wire
Bruker Corporation (Nasdaq: BRKR) today announced it will report
fourth quarter and fiscal year 2021 financial results before market
opening on Friday, February 11, 2022. The Company will host a
conference call and webcast at 8:30 a.m. Eastern Standard Time to
discuss the results and current business trends.
To listen to the webcast, investors can go to
https://ir.bruker.com and click on the “Q4 2021 Earnings Webcast”
hyperlink in the “Events & Presentations” section. A slide
presentation will be referenced during the webcast and will be
posted to the Company’s website shortly before the webcast
begins.
Investors can also listen to the earnings webcast via telephone
by dialing 1-888-437-2685 (U.S. toll free) or +1-412-317-6702
(international) and referencing “Bruker’s Fourth Quarter 2021
Earnings Conference Call”.
Bruker is enabling investors to pre-register for the earnings
conference call so that they can expedite their entry into the call
and avoid the need to wait for a live operator. In order to
pre-register for the call, investors can visit
https://dpregister.com/sreg/10163678/f150b39272 and enter
their contact information. Investors will then be issued a
personalized phone number and PIN to dial into the live conference
call. Individuals can pre-register any time prior to the start of
the conference call on February 11.
A telephone replay of the conference call will be available by
dialing 1-877-344-7529 (U.S. toll free) or +1-412-317-0088
(international) and entering replay access code: 5295955. The
replay will be available beginning one hour after the end of the
conference call through March 11, 2022.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high performance scientific instruments and high
value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular and cell biology research, in applied and pharma
applications, in microscopy and nanoanalysis, as well as in
industrial applications. Bruker offers differentiated, high-value
life science and diagnostics systems and solutions in preclinical
imaging, clinical phenomics research, proteomics and multiomics,
spatial and single-cell biology, functional structural and
condensate biology, as well as in clinical microbiology and
molecular diagnostics. For more information, please visit:
www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220202005367/en/
Justin Ward Sr. Director, Investor Relations & Corporate
Development Bruker Corporation T: +1 (978) 663-3660 x1479 E:
Investor.Relations@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Oct 2023 to Oct 2024